Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern
- 1 February 1987
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 65 (2) , 187-191
- https://doi.org/10.1111/j.1365-2141.1987.tb02263.x
Abstract
An abnormal AT III variant was found in five members from a family where a high incidence of thromboembolism occurred. In all the affected subjects AT III antigen concentration was normal, whereas antithrombin and antifactor Xa progressive activities as well as heparin cofactor activities were low. Crossed immunoelectrophoresis performed either in absence or in presence of heparin showed a normal plasma pattern. Further chromatographic investigations showed a normal affinity to heparin. An abnormal plasma pattern was evidentiated by crossed immunoelectrofocusing throughout all the AT III pH range. These data are consistent with the presence of an abnormal AT III variant with a defective binding to serine proteases and clearly identifiable only by crossed immunoelectrofocusing. This variant appeared different from the other qualitative AT III defects so far described and was named ''Antithrombin III Pescara''.This publication has 20 references indexed in Scilit:
- A functional abnormal antithrombin III (AT III) deficiency : AT III CharlevilleThrombosis Research, 1985
- An abnormal plasma antithrombin with no apparent affinity for heparinThrombosis Research, 1984
- Antithrombin III TrentoActa Haematologica, 1984
- Immunoelectrophoretic evidence of a thrombin-induced abnormality in a new variant of hereditary dysfunctional antithrombin III (AT III ‘Vicenza’)British Journal of Haematology, 1983
- Antithrombin III toyama: A hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitisThrombosis Research, 1983
- A family with heterozygous factor X friuli defect outside friuliAnnals of Hematology, 1983
- A new familial variant of antithrombin III: ‘Antithrombin III Paris’British Journal of Haematology, 1982
- Distinction of two pathologic antithrombin III molecules: Antithrombin III ‘Aalborg’ and antithrombin III ‘Budapest’Thrombosis Research, 1982
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- Investigations on Antithrombin III in Normal Plasma and SerumBritish Journal of Haematology, 1975